acetazolamide has been researched along with Cerebromeningitis in 4 studies
Acetazolamide: One of the CARBONIC ANHYDRASE INHIBITORS that is sometimes effective against absence seizures. It is sometimes useful also as an adjunct in the treatment of tonic-clonic, myoclonic, and atonic seizures, particularly in women whose seizures occur or are exacerbated at specific times in the menstrual cycle. However, its usefulness is transient often because of rapid development of tolerance. Its antiepileptic effect may be due to its inhibitory effect on brain carbonic anhydrase, which leads to an increased transneuronal chloride gradient, increased chloride current, and increased inhibition. (From Smith and Reynard, Textbook of Pharmacology, 1991, p337)
| Excerpt | Relevance | Reference |
|---|---|---|
| "Pseudotumor cerebri is an unusual presentation of Lyme disease." | 2.40 | Pseudotumor cerebri in Lyme disease: a case report and literature review. ( Kan, L; Maytal, J; Sood, SK, 1998) |
| " The objective of the study was to investigate the efficacy of acetazolamide (AZA), candesartan (CAN), and triciribine (TCBN), in combination with the antifungal fluconazole, on C." | 1.91 | A multi-arm, parallel, preclinical study investigating the potential benefits of acetazolamide, candesartan, and triciribine in combination with fluconazole for the treatment of cryptococcal meningoencephalitis. ( Alanazi, AH; Chastain, DB; Franco-Paredes, C; Henao-Martínez, AF; Lin, X; Narayanan, SP; Parvathagiri, V; Rudraraju, M; Shan, S; Somanath, PR, 2023) |
| "The patient was diagnosed with ME and hydrocephalus." | 1.72 | Meningoencephalitis and postinflammatory hydrocephalus in the course of COVID-19 disease in newborn - the potential role of acetazolamide as add-on therapy to the standard treatment. ( Bryda, J; Wątroba, SJ, 2022) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (25.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 3 (75.00) | 2.80 |
| Authors | Studies |
|---|---|
| Wątroba, SJ | 1 |
| Bryda, J | 1 |
| Finsterer, J | 1 |
| Scorza, FA | 1 |
| Alanazi, AH | 1 |
| Chastain, DB | 1 |
| Rudraraju, M | 1 |
| Parvathagiri, V | 1 |
| Shan, S | 1 |
| Lin, X | 1 |
| Henao-Martínez, AF | 1 |
| Franco-Paredes, C | 1 |
| Narayanan, SP | 1 |
| Somanath, PR | 1 |
| Kan, L | 1 |
| Sood, SK | 1 |
| Maytal, J | 1 |
1 review available for acetazolamide and Cerebromeningitis
| Article | Year |
|---|---|
Pseudotumor cerebri in Lyme disease: a case report and literature review.
Topics: Abducens Nerve; Acetazolamide; Borrelia burgdorferi Group; Carbonic Anhydrase Inhibitors; Ceftriaxon | 1998 |
3 other studies available for acetazolamide and Cerebromeningitis
| Article | Year |
|---|---|
Meningoencephalitis and postinflammatory hydrocephalus in the course of COVID-19 disease in newborn - the potential role of acetazolamide as add-on therapy to the standard treatment.
Topics: Acetazolamide; Child; COVID-19; Humans; Hydrocephalus; Infant, Newborn; Meningoencephalitis; SARS-Co | 2022 |
If SARS-CoV-2 is blamed for causing meningoencephalitis, the virus must be detected in the CSF.
Topics: Acetazolamide; COVID-19; Humans; Male; Meningoencephalitis; SARS-CoV-2; Seizures | 2023 |
A multi-arm, parallel, preclinical study investigating the potential benefits of acetazolamide, candesartan, and triciribine in combination with fluconazole for the treatment of cryptococcal meningoencephalitis.
Topics: Acetazolamide; Animals; Antifungal Agents; Cryptococcus neoformans; Fluconazole; Humans; Meningitis, | 2023 |